Pfizer, BioNTech Seek COVID Vaccine Authorization For Kids

FILE - In this March 27, 2021 file photo a laboratory worker simulates the workflow in a cleanroom of the BioNTech Corona vaccine production in Marburg, Germany, during a media day. Ugur Sahin, BioNTech's chief executive, which developed the first widely approved COVID-19 vaccine with U.S. partner Pfizer, said Europe can achieve 'herd immunity' against the coronavirus within the next four months. (AP Photo/Michael Probst, file)

(AP) — Pfizer and BioNTech have submitted a request to the European drug regulator for the approval of their coronavirus vaccine to be extended to include children aged 12 to 15 years old, in a move that could offer younger and less at-risk populations in Europe access to the shot for the first time. The two pharmaceuticals said their submission to the European Medicines Agency is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective. The COVID-19 vaccine made by Pfizer and BioNTech was the first one to be granted a greenlight by the EMA last December.


Europe’s Economy Shrinks In First Quarter As US Rolls Ahead

Previous article

No Charges To Result From Probe Of Lobbyist Accused Of Drugging Capitol Aide

Next article

You may also like